The Effect of Convalescent Plasma Therapy on Patients with 19-COVID

Phase 1

Recruiting

• Conditions: covid 19.; COVID-19; U07.1

• Registration Number: IRCT20150808023559N21
• Lead Sponsor: Ardabil University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Definitive diagnosis of Covid19 based on PCR
Blood oxygen saturation less than 90%
No recovery within 48 hours of routine treatment

Exclusion Criteria

History of allergic reactions to blood products injection

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in all causes mortality. Timepoint: At the time of discharge of patients. Method of measurement: Patient documents.

Secondary Outcome Measures

Name	Time	Method
Reduction of hospital stay. Timepoint: At the time of discharge of patients. Method of measurement: Patient documents.